Valvulopathies and Genetics: Where are We?

Area of Science:

• Cardiovascular Medicine
• Genetics
• Molecular Biology

Background:

• Valvulopathies are common cardiovascular diseases with significant morbidity and mortality.
• While often acquired, valvular heart diseases have a notable genetic component, especially mitral valve prolapse and bicuspid aortic valve.
• These genetic links can be syndromic (e.g., Marfan, Turner syndromes) or non-syndromic, appearing familial or sporadically.

Purpose of the Study:

• To review the numerous genetic contributors to heart valve diseases.
• To highlight the importance of identifying genetic factors for at-risk familial carrier identification.
• To underscore the role of genetic discoveries in developing novel therapeutic strategies.

Main Methods:

• Literature review of genetic contributors to valvulopathies.
• Discussion of genetic syndromes associated with valvular heart disease.
• Exploration of molecular pathways and genetic elements involved.

Main Results:

• Valvular heart diseases, including mitral valve prolapse and bicuspid aortic valve, have significant genetic underpinnings.
• Genetic factors can manifest in syndromic or non-syndromic forms, with familial clustering observed.
• Identification of genetic contributors is crucial for clinical applications.

Conclusions:

• Genetic factors play a critical role in the etiology of valvular heart diseases.
• Further research into genetic elements, regulatory mechanisms, and molecular pathways is essential.
• Understanding genetic contributions will facilitate early detection and targeted therapies for valvulopathies.